Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ICPT

Intercept

$61.56

0.84 (1.38%)

, CBAY

CymaBay

$5.57

-0.02 (-0.36%)

07:40
08/08/19
08/08
07:40
08/08/19
07:40
Recommendations
Intercept, CymaBay analyst commentary at Oppenheimer »

Intercept price target…

ICPT

Intercept

$61.56

0.84 (1.38%)

CBAY

CymaBay

$5.57

-0.02 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$5.57

-0.02 (-0.36%)

17:04
08/07/19
08/07
17:04
08/07/19
17:04
Earnings
CymaBay reports Q EPS (35c), consensus (37c) »

The company held $241.2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

CBAY

CymaBay

$6.05

-0.09 (-1.47%)

08:09
08/05/19
08/05
08:09
08/05/19
08:09
Hot Stocks
CymaBay appoints Janet Dorling as CCO »

CymaBay Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

GLMD

Galmed

$5.70

(0.00%)

07:06
08/05/19
08/05
07:06
08/05/19
07:06
Earnings
Breaking Earnings news story on Galmed »

Galmed reports Q2 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Aug

CBAY

CymaBay

$6.14

-0.03 (-0.49%)

17:08
08/01/19
08/01
17:08
08/01/19
17:08
Hot Stocks
Integrated Core Strategies reports 5.4% passive stake in CymaBay »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

GLMD

Galmed

$6.27

-0.11 (-1.72%)

07:50
07/22/19
07/22
07:50
07/22/19
07:50
Initiation
Galmed initiated at Laidlaw »

Galmed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLMD

Galmed

$6.40

0.1 (1.59%)

, CBAY

CymaBay

$6.26

-0.13 (-2.03%)

14:25
07/18/19
07/18
14:25
07/18/19
14:25
Conference/Events
Cantor Fitzgerald biotech analysts to hold a KOL luncheon meeting »

Biotech Analysts Young…

GLMD

Galmed

$6.40

0.1 (1.59%)

CBAY

CymaBay

$6.26

-0.13 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GLMD

Galmed

$6.30

-0.2 (-3.08%)

, CBAY

CymaBay

$6.39

-0.15 (-2.29%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Cantor Fitzgerald biotech analysts to hold a KOL luncheon meeting »

Biotech Analysts Young…

GLMD

Galmed

$6.30

-0.2 (-3.08%)

CBAY

CymaBay

$6.39

-0.15 (-2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

Over a month ago
GLMD

Galmed

$6.78

0.16 (2.42%)

, CBAY

CymaBay

$6.79

0.29 (4.46%)

14:18
07/09/19
07/09
14:18
07/09/19
14:18
Conference/Events
Cantor Fitzgerald biotech analysts to hold a KOL luncheon meeting »

Biotech Analysts Young…

GLMD

Galmed

$6.78

0.16 (2.42%)

CBAY

CymaBay

$6.79

0.29 (4.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBAY

CymaBay

$6.76

-0.32 (-4.52%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58
Initiation
CymaBay initiated at Stifel »

CymaBay initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.